146 related articles for article (PubMed ID: 26637887)
41. Alpha-fetoprotein in germ cell tumors. An immunohistochemical study.
Chaudhary RK; Kher A; Bobhate SK; Grover S
Indian J Pathol Microbiol; 1989 Jul; 32(3):167-73. PubMed ID: 2476392
[TBL] [Abstract][Full Text] [Related]
42. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
Malagón HD; Valdez AM; Moran CA; Suster S
Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
[TBL] [Abstract][Full Text] [Related]
43. Establishment and Characterization of a Novel Primitive Yolk Sac Tumour Cell Line, TC587.
Iwasaki T; Kohashi K; Ohno M; Taguchi T; Oda Y
Anticancer Res; 2020 Feb; 40(2):759-766. PubMed ID: 32014918
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathologic Characteristics and Survival of Patients with Rare Malignant Ovarian Yolk Sac Tumors: A Population-based Analysis.
Wang T; Wang B; Wang SX; Wu MF
Curr Med Sci; 2021 Apr; 41(2):342-347. PubMed ID: 33877552
[TBL] [Abstract][Full Text] [Related]
45. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery].
Schröder W
Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476
[TBL] [Abstract][Full Text] [Related]
46. [Characteristics of extracranial malignant germ cell tumours in two age groups of children (0-10 and 10-18 years). Multicentre experiences].
Drozyńska E; Połczyńska K; Popadiuk S; Niedzwiecki M; Wiśniewski J; Balcerska A; Izycka-Swieszewska E; Bilska K; Balwierz W; Chełmecka L; Chybicka A; Dudeńko I; Karolczyk G; Kowalczyk J; Krawczuk-Rybak M; Kurylak A; Leszczyńska E; Matysiak M; Młynarski W; Pobudejska A; Sobol G; Sońta-Jakimczyk D; Szajdak K; Tredowska-Skoczeń D; Szmyd K; Trelińska J; Urasiński T; Wachowiak J; Wieczorek M; Wiśniewska-Slusarz H; Woźniak S; Woźniak W; Wysocki M
Med Wieku Rozwoj; 2011; 15(1):16-24. PubMed ID: 21786508
[TBL] [Abstract][Full Text] [Related]
47. Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
[TBL] [Abstract][Full Text] [Related]
48. The pluripotential nature of the mesenchyme-like component of yolk sac tumor.
Michael H; Ulbright TM; Brodhecker CA
Arch Pathol Lab Med; 1989 Oct; 113(10):1115-9. PubMed ID: 2478105
[TBL] [Abstract][Full Text] [Related]
49. [Malignant ovarian germ cell tumors. Current status of diagnosis and treatment].
Torres-Lobatón A
Ginecol Obstet Mex; 2014 Mar; 82(3):177-87. PubMed ID: 24779273
[TBL] [Abstract][Full Text] [Related]
50. Molecular genetic analysis of bilateral ovarian germ cell tumors.
Hennes E; Zahn S; Lopes LF; Schönberger S; Leuschner I; Göbel U; Calaminus G; Schneider DT
Klin Padiatr; 2012 Oct; 224(6):359-65. PubMed ID: 23143763
[TBL] [Abstract][Full Text] [Related]
51. High-grade serous carcinoma of fallopian tube with yolk sac tumor differentiation in a postmenopausal patient.
Xing F; Jiang L; Wang T; Li W; Yang P; Qu G; Bao L
Int J Clin Exp Pathol; 2020; 13(6):1415-1420. PubMed ID: 32661478
[TBL] [Abstract][Full Text] [Related]
52. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
[TBL] [Abstract][Full Text] [Related]
53. [Results of fertility preserving operations in malignant ovarian tumors].
Kleine W
Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
[TBL] [Abstract][Full Text] [Related]
54. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
55. Expression of glypican 3 in ovarian and extragonadal germ cell tumors.
Zynger DL; Everton MJ; Dimov ND; Chou PM; Yang XJ
Am J Clin Pathol; 2008 Aug; 130(2):224-30. PubMed ID: 18628091
[TBL] [Abstract][Full Text] [Related]
56. [Malignant ovarian germ cell tumours: a trial of 36 cases].
Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
[TBL] [Abstract][Full Text] [Related]
57. [Ovarian germ cell tumors in girls].
Nechushkina IV; Karseladze AI
Vopr Onkol; 2015; 61(2):239-43. PubMed ID: 26087605
[TBL] [Abstract][Full Text] [Related]
58. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
[TBL] [Abstract][Full Text] [Related]
59. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.
Gadducci A; Lanfredini N; Tana R
Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194
[TBL] [Abstract][Full Text] [Related]
60. Subsequent ovarian yolk sac tumor after operation of ovarian mature teratoma: a case report and review of the literature.
Li S; Peng J; Zhang Y; Liu D; Li L; Nai M
Front Oncol; 2023; 13():1327724. PubMed ID: 38298441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
